Top Business Stories from the U.S.
Updated: 9 hours 50 min ago
Ukrainian forces came under attack by Russian regular forces north of the conflict zone in Eastern Ukraine.
Are McDonald's fries even made of potatoes? Why are there 17 ingredients in its fries? The fast-food giant is out to dispel myths...
Facebook would like credit for the Internet.
Survey results indicate that the U.S. is first choice for 38 percent, compared to 34 percent for China.
White House and British Parliament agree to maintain strong sanctions against Russia, The Fiscal Times reports.
President Obama's proposed cybersecurity policy, if passed, may not address the fundamental threat to businesses and consumers.
Former House Majority Leader Eric Cantor said he fears Obama's State of the Union will "inflame and conflict" with the new Republican Congress.
BofA's CEO tells CNBC the bank made money off the Swiss currency shocker even though it "caught everybody by surprise."
Analysts recommend housing and basic economy-related stocks for the best trade around the State of the Union.
Auto dealerships are experiencing a rare combination: strong demand, strong pricing and no sign of it slowing down.
Back on this week, the World Economic Forum in Davos is as big as ever with lofty ambitions to match.
Out of the top 25, nine passwords contained only numbers, from variations on “123456” to “111111”.
The hackers behind the Sony attack took advantage of what's known as a 'Zero-Day' vulnerability, Re/code reports.
By a growing stack of indicators, 2015 may be the year Main Street finally hits a comeback.
CNBC's Jim Cramer said on Tuesday the Chinese are changing their economy into an internal consumption economy.
Morgan Stanley earnings rose as its legal costs fell, outweighing a big drop in revenue from bond, currency, and commodities trading.
Delta Air Lines said it lost $712 million last quarter largely due to fuel hedge settlements, although the carrier topped analysts' estimates.
The U.S. Supreme Court ruled for Teva Pharmaceutical Industries in its fight with generic drug manufacturers.
Johnson & Johnson reported lower-than-expected sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.